SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012756
Filing Date
2022-08-09
Accepted
2022-08-09 07:47:38
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20220630x10q.htm   iXBRL 10-Q 1913308
2 EX-31.1 xlo-20220630xex31d1.htm EX-31.1 11952
3 EX-31.2 xlo-20220630xex31d2.htm EX-31.2 11852
4 EX-32.1 xlo-20220630xex32d1.htm EX-32.1 7922
  Complete submission text file 0001558370-22-012756.txt   5930572

Data Files

Seq Description Document Type Size
5 EX-101.SCH xlo-20220630.xsd EX-101.SCH 38511
6 EX-101.CAL xlo-20220630_cal.xml EX-101.CAL 39935
7 EX-101.DEF xlo-20220630_def.xml EX-101.DEF 136853
8 EX-101.LAB xlo-20220630_lab.xml EX-101.LAB 354534
9 EX-101.PRE xlo-20220630_pre.xml EX-101.PRE 269819
59 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20220630x10q_htm.xml XML 814445
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 221146444
SIC: 2834 Pharmaceutical Preparations